Drug intelligence / Profile preview

Neurodana

Development stage
Unknown
Lead developer
Blue Heron Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Neurodana is a medical food or dietary supplement capsule marketed by Blue Heron Pharmaceuticals for the clinical dietary management of nutritional deficiencies, particularly those associated with peripheral neuropathy. The product contains a combination of active B-vitamin metabolites: L-methylfolate calcium (3 mg), pyridoxal 5-phosphate (35 mg), and methylcobalamin (2 mg). These components are essential for maintaining healthy nerve function, supporting the synthesis of neurotransmitters, and regulating homocysteine levels, which can be elevated in patients with diabetic neuropathy or other neurodegenerative conditions. By providing these vitamins in their bioactive forms, Neurodana bypasses the need for enzymatic conversion, which may be impaired in certain patient populations.

Brand names
Neurodana
Other names
Neurodana Capsule
02

Targets

MTR (Methionine synthase)CBS (Cystathionine beta-synthase)DDC (Aromatic L-amino acid decarboxylase)

Beyond the preview

Go deeper on Neurodana.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurodana.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call